JICC01.14 Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer after Platinum-Based Chemotherapy

• DOI: 10.1016/j.jtho.2021.01.164
• Publication Date: 2021-03-20T01:53:16Z
• Authors: Q. Zhou; Y. Wu; J. Chang; Y. Fan; J. Zhao; G. Wu; Y. Sun; X. Wang; W. Nian; K. Wang; X. Zheng; L. Qu; S. Yao; K. Liu; P. Li; J. Yang
• Keywords: Targeted Therapy